RUA Life Sciences (LON:RUA) Issues Earnings Results

RUA Life Sciences (LON:RUA) posted its quarterly earnings data on Tuesday. The company reported GBX (0.33) earnings per share for the quarter, Digital Look Earnings reports. RUA Life Sciences had a negative net margin of 3.26% and a negative return on equity of 2.03%.

RUA Life Sciences Stock Performance

RUA Life Sciences stock remained flat at GBX 19 during midday trading on Friday. 164,275 shares of the company’s stock traded hands, compared to its average volume of 239,799. The company has a debt-to-equity ratio of 18.95, a quick ratio of 7.32 and a current ratio of 4.64. The stock has a market cap of £11.79 million, a PE ratio of -2.61 and a beta of 0.96. RUA Life Sciences has a 52 week low of GBX 10.42 and a 52 week high of GBX 26.80. The business has a 50-day moving average price of GBX 19.96 and a 200 day moving average price of GBX 16.

About RUA Life Sciences

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.